Log In
Print
BCIQ
Print
Print this Print this
 

PA32540

  Manage Alerts
Collapse Summary General Information
Company Pozen Inc.
DescriptionTablet containing 325 mg aspirin core surrounded by an immediate-release coating of 40 mg omeprazole, a proton pump inhibitor (PPI)
Molecular Target H+/K ATPase pump
Mechanism of ActionH+/K+ ATPase pump inhibitor
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentRegistration
Standard Indication Cardiovascular (unspecified)
Indication DetailsSecondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers; Secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcers; Secondary prevention of cardiovascular events
Regulatory Designation

U.S. - Standard Review (Secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcers)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today